Raphael Fraser, PhD

Publications

• Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care.

  (Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM.) J Pediatr Hematol Oncol. 2020 May 12 PMID: 32404689 SCOPUS ID: 2-s2.0-85085583670 05/15/2020

• Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

  (Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A.) Leukemia. 2020 Apr 20 PMID: 32313109 SCOPUS ID: 2-s2.0-85083712292 04/22/2020

• Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit.

  (Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC.) J Allergy Clin Immunol Pract. 2020 Mar;8(3):1126-1128.e1 PMID: 31586667 PMCID: PMC7332348 SCOPUS ID: 2-s2.0-85073824604 10/07/2019

• Racial disparities of liver cancer mortality in Wisconsin.

  (Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM.) Cancer Causes Control. 2019 Dec;30(12):1277-1282 PMID: 31531799 PMCID: PMC6858574 SCOPUS ID: 2-s2.0-85073816952 09/19/2019

• Reported Knowledge and Management of Potential Penicillin Allergy in Children.

  (Vyles D, Mistry RD, Heffner V, Drayna P, Chiu A, Visotcky A, Fraser R, Brousseau DC.) Acad Pediatr. 2019 08;19(6):684-690 PMID: 30703582 SCOPUS ID: 2-s2.0-85063442775 02/01/2019

• Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

  (Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P.) Biol Blood Marrow Transplant. 2019 06;25(6):1099-1106 PMID: 30794931 PMCID: PMC6559839 SCOPUS ID: 2-s2.0-85064954131 02/23/2019

• Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.

  (Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P.) Biol Blood Marrow Transplant. 2019 04;25(4):683-688 PMID: 30579965 PMCID: PMC6453717 SCOPUS ID: 2-s2.0-85060511135 12/24/2018

• Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).

  (Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J.) Lancet Haematol. 2019 Mar;6(3):e132-e143 PMID: 30824040 PMCID: PMC6503965 SCOPUS ID: 2-s2.0-85061920512 03/03/2019

• Impact of Medical Scribes on Provider Efficiency in the Pediatric Emergency Department.

  (Addesso LC, Nimmer M, Visotcky A, Fraser R, Brousseau DC.) Acad Emerg Med. 2019 02;26(2):174-182 PMID: 30069952 SCOPUS ID: 2-s2.0-85055480393 08/03/2018

• Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

  (Hahn, T.E., Wallace, P.K., Fraser, R., Fei, M., Tario, J.D., Howard, A., Zhang, Y., Blackwell, B., Brunstein, C.G., Efebera, Y.A. and Geller, N..) Biology of Blood and Marrow Transplantation , Volume 25 , Issue 3 , S4 - S6. 03/01/2019

• Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.

  (Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A.) Biol Blood Marrow Transplant. 2018 12;24(12):2443-2449 PMID: 30142419 PMCID: PMC6293469 SCOPUS ID: 2-s2.0-85054709914 08/25/2018

• Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT)

  (Kilari, D., Hari, P., Qayed, M., Fraser, R., Davila, O., Kumar, S., Mark, T.M., Nieto, Y. and D'Souza, A..) Journal of Clinical Oncology. 2018 36:6_suppl, 572-572 07/01/2019